Juvent Names Scott D. Boden, MD as Chief Medical Advisor

RIVIERA BEACH, FL–(Marketwired – June 07, 2017) – Juvent (www.juvent.com) a leader in orthopaedic regenerative therapies for bone and musculoskeletal health announced today the engagement of Scott D. Boden, MD as Chief Medical Advisor. Dr. Boden is a tenured Professor of Orthopaedic Surgery at the Emory University School of Medicine and serves as the Director of the Emory Orthopeadics & Spine Center, Vice Chair of Orthopaedics, CMO/CQO of The Emory University Orthopaedics & Spine Hospital, and Emory Healthcare Physician Director of Strategy and Development for Orthopaedics & Spine Programs.

Dr. Boden has received numerous awards for his work and is the author of more than 175 peer-reviewed articles on spine and basic science topics; as well as 30 chapters and seven textbooks. He is co-editor of Seminars in Spine Surgery, a deputy editor of SPINE, and a reviewer for the Journal of Bone and Joint Surgery, the Journal of Bone and Mineral Research, and the European Spine Journal.

“Dr. Boden brings in-depth experience and perspective to our group and has a unique blend of medicine, science, and business skills,” said Rush Simonson, Chairman & CEO of Regenerative Technologies Corporation. “His reputation and expertise will help us in our quest to expand the clinical value of the Juvent technology.”

In 2013, Dr. Boden served as President of the American Orthopaedic Association. He received his B.A. and M.D. from the University of Pennsylvania and completed an Orthopaedic Residency at The George Washington University Medical Center, followed by a Spine Fellowship at Case Western Reserve University Hospitals.

Additionally, Dr. Boden, Emory Orthopaedics and Spine are also pioneering a sports team and academic health-care partnership with the Atlanta Hawks and P3 (Peak Performance Project) in a soon to open 90,000-square foot, $50 million-dollar facility. Juvent is playing an ever-increasing role in professional sports as their device helps to rehab athletes and speed recovery time after training. Olympic gold medal tennis champion, Mike Bryan, uses Juvent daily as well as many other national football players, such as Eric Wood, Center with the Buffalo Bills.

Juvent’s presence in physical therapy centers continues to grow with one leading therapy franchise putting over 80% of their patients on Juvent at each visit. “Dr. Boden’s experience and expertise in bone health is widely recognized and he will help drive Juvent’s product development and clinical applications,” said Juvent President, Peter Simonson.

“We are just before entering our next round of funding to complete development and production of a low-cost consumer unit to meet the demand of a broader consumer market. Over 50 million people who suffer from osteoarthritis in the U.S. could benefit from this safe, non-invasive technology,” said Chairman & CEO Rush Simonson.

Juvent’s Micro-Impact Platform^® is registered as a FDA Class I medical exercise and rehabilitation device. Juvent uses a unique, patented resonant wave technology to deliver thousands of low-magnitude and high-frequency micro-impacts that enter through the heels of the feet and move up the entire body. These micro-impacts safely stimulate the body’s muscles and bones to rebuild. Users stand on the Juvent for as little as 10 minutes per day and many begin to feel joint pain relief within days. Juvent’s platform is recommended and used by world-renowned trainers, doctors, physical therapists, and chiropractors. Juvent holds over 26 patents worldwide on its technology.

Juvent’s platform is also used in the athletic world for recovery and healing by leading organizations such as The David Leadbetter Golf Academy, NFL Alumni Association (NFLA), and Hospital for Special Surgery’s, Pete Draovitch, PT, MS, ATC, CSCS. Some of the champion athletes using Juvent in their daily training regimens include; Olympic Tennis Champion Mike Bryan, former NFL legend, Ray Lewis, Eric Wood, with the Buffalo Bills and tennis legend Mats Wilander.

Juvent is a Corporate Advisory Roundtable Member of the National Osteoporosis Foundation (NOF).

About Juvent:

Juvent is a part of Regenerative Technologies Corporation, a privately held, Florida based company who manufactures the Juvent Micro-Impact Platform^® here in the U.S. The platform provides non-invasive, micro-impact pulses to support bone health, lymphatic drainage, relieve joint and back pain, and enhance balance. The Class I medical exercise and rehabilitation device is the result of more than 20 years and $45 million in R&D, with many peer-reviewed journals articles and 6 human clinical studies (completed or current) with backing from the National Institutes of Health (NIH), NASA, and the U.S. Army. Used by world-renowned medical doctors, trainers, physical therapists, and chiropractors, for more information, visit www.juvent.com or follow us on Twitter @JuventHealth, Facebook Juvent Health and, Facebook Juvent Sports

In the U.S., the Juvent 1000N device is considered investigational for the treatment of osteoporosis or improvement/maintenance of bone mineral density (BMD).

Image Available: http://www.marketwire.com/library/MwGo/2017/6/6/11G140561/Images/Scott_D._Boden,_MD_2017-629ecab0215885c7bb1a88ab05d2c83d.jpg